Secnidazole

This classification denotes an antiprotozoal agent with the molecular formula C7H11N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R3459K699K, chemically known as imidazole-1-ethanol, alpha,2-dimethyl-5-nitro- but generally known as secnidazole, which bears US NIH Compound Identifier 71815. European Medicines Agency schedules Secnidazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10467MIG. The term SECNIDAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). World Health Organization schedules secnidazole in its Anatomical Therapeutic Chemical (ATC) Classification. SECNIDAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule secnidazole under HS 29332990 and SITC 51573. As of Q4 2014, SECNIDAZOLE remains the US FDA Preferred Term for this commodity. Secnidazole bears US NLM identifiers UMLS ID C0074246 and NCI Concept Code C66529. SMILES: OC(CN1C(NCC1[N](=O)O)C)C.